StonvexLoading…
StonvexStonvexStonvexCore line items from SAH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.69B | $15.15B | $11.28B | $7.31B |
Operating Income | $132.70M | $367.50M | $244.30M | $121.60M |
Net Income | $60.80M | $118.70M | $71.80M | $25.00M |
EPS (Diluted) | $1.79 | $3.42 | $2.06 | $0.72 |
Total Assets | $6.12B | $5.97B | $6.02B | $5.93B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $5.70M | $6.30M | $89.40M | $110.40M |
Free Cash Flow OCF − CapEx | $-1.50M | $417.50M | $387.90M | $253.50M |
Shares Outstanding | 34.00M | 34.70M | 34.80M | 34.70M |